Suppression of transplanted rat sarcomata mediated by Bacillus Calmette Guéin (BCG).
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D002470:Cell Survival; D002478:Cells, Cultured; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology / Q000628:therapy; D007110:Immunity, Active; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009368:Neoplasm Transplantation; D012516:Osteosarcoma / Q000276:immunology / Q000628:therapy; D051381:Rats; D012513:Sarcoma, Experimental / Q000517:prevention & control / Q000628:therapy*; D014184:Transplantation, Homologous; D014373:Tuberculin
D001500:BCG Vaccine; D014373:Tuberculin